We first identified arfaptin as a protein that bound to GTP-ARFs (especiall
y ARF1). However, a second group reported that PORI, a truncated form of ar
faptin, bound to GTP-Rac1. Therefore, we examined the possibility that arfa
ptin 2/POR1 was a common downstream effector for both ARF1 and Rac1. In thi
s study, we found that constitutively active Rac1 or GTP-Rac1 showed neglig
ible or no binding to arfaptin 2/POR1 in a yeast two-hybrid assay or a GST
pull-down assay. However, wild-type or dominant negative Rac1 or Rac1 ligan
ded to GDP showed strong binding. In contrast, constitutively active ARFs1,
5, and 6 showed binding, whereas the wild-type and dominant negative forms
did not. Furthermore, the GTP-liganded ARFs bound arfaptin 2, whereas the
GDP-bound forms showed little or no binding. Based on these observations, w
e suggest that arfaptin 2/POR1 is a target protein for GTP-ARFs and for GDP
-Rac1, and that it may be involved in interactions between the Rac and ARF
signaling pathways. (C) 2001 Academic Press.